Skip to main content

Find Clinical Trials

Home
Conditions
Persistent Isolated Chemotherapy-Induced Thrombocytopenia

Clinical trial condition

Persistent Isolated Chemotherapy-Induced Thrombocytopenia

Explore clinical trials studying Persistent Isolated Chemotherapy-Induced Thrombocytopenia. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Persistent Isolated Chemotherapy-Induced Thrombocytopenia trial results

Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

NCT07586813

Conditions: Blood Platelet Disorders, Chemotherapy-Induced Thrombocytopenia, Colonic Diseases, +26 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

NCT07586826

Conditions: Adnexal Diseases, Blood Platelet Disorders, Breast Cancer, +51 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details